Questcor Pharmaceuticals (QCOR +0.6%) is mildly positive after preannouncing Q4 revenue of $75M...

|By:, SA News Editor

Questcor Pharmaceuticals (QCOR +0.6%) is mildly positive after preannouncing Q4 revenue of $75M ($68.2M consensus) and operating income of $41M-$43M, and attributing the numbers to strong sales of its Acthar gel. Questcor shares were hammered last month thanks to a critical report issued by TheStreetSweeper.